B. Braun Melsungen AG, a leading name in the medical technology sector, is headquartered in Melsungen, Germany. Founded in 1839, the company has established itself as a key player in the development and manufacturing of precision medical instruments, with a focus on areas such as infusion therapy, pain management, and surgical instruments.
With a strong global presence, B. Braun operates in numerous regions, including Europe, Asia, and the Americas, providing innovative solutions that enhance patient care. The company is renowned for its commitment to quality and safety, offering a diverse range of products that include intravenous therapy systems and wound care solutions.
B. Braun's dedication to research and development has positioned it as a market leader, consistently achieving notable milestones in medical advancements and sustainability initiatives.
-6 vs industry average
B. Braun Melsungen AG’s score of 21 is lower than 42% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at B. Braun Melsungen AG?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Medical Device Manufacturing has typical carbon intensity
Industry performance
The Medical Device Manufacturing industry has reduced its overall emissions by 18% since 2019
Emissions trajectory 2020 – 2026
Reported emissions
Scope 3 accounts for ••• of total emissions.
B. Braun Melsungen AG's reported carbon emissions
B. Braun Melsungen AG, a company in the medical, precision and optical instruments industry headquartered in DE, has reported its Scope 1 and 2 emissions for recent years. In 2023, the company's Scope 1 and 2 emissions were approximately 568,000,000 kg CO2e. This represents a reduction from 2022, when Scope 1 and 2 emissions were approximately 612,300,000 kg CO2e, and 2021, when they stood at approximately 653,400,000 kg CO2e.
B. Braun Melsungen AG has established significant climate commitments. The company aims to achieve Net Zero for all emissions by 2045. Furthermore, it has committed to a near-term target of reducing its Gross Greenhouse-Gas Scope 1 and 2 Carbon Dioxide emissions by 50% by the end of 2030, compared to a 2019 baseline. While Scope 3 emissions data is not fully disclosed, the company notes missing data points for "purchased goods and services."
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
B. Braun Melsungen AG’s Climate Goals (2030 & 2050)
2 goals2030
50% reduction in Scope 1
Set a target and commit to reduce our Gross Greenhouse-Gas Scope 1 and 2 Carbon Dioxide emissions by 50% by the end of 2030, and aim to beco…
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 2 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
B. Braun Melsungen AG
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project